Open AccessP1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B‐LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES
Author(s) -
Taghi Khani A.,
Kumar A.,
Radecki K.,
Lee S. J.,
Sanchez Ortiz A.,
Lorenson M.,
Wu X.,
Koff J.,
Forman S.,
Gu Z.,
Walker A.,
Swaminathan S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848048.13001.58
Subject(s) - b cell , cancer research , biology , cell growth , gene knockdown , immunology , apoptosis , antibody , genetics , biochemistry